Seringues préremplies - Partie 8: Exigences et méthodes d’essai pour seringues préremplies prêtes à l’emploi
Introduction: Historically, injectable (parenteral) liquid pharmaceutical products have been mainly provided in primary containers (i.e. ampoules and vials) which required the liquid to be transferred into a hypodermic syringe and combined with the appropriate injection needle before administration. This procedure is not only time- consuming, but also presents a multitude of possibilities for contamination and use errors. Over the past decades, the presentation of liquid pharmaceutical products in prefilled syringes for single use, many with staked needles, has become more prevalent. The simplicity of use that is provided not only benefits their use in the clinical setting, but also enables these to be used by lay users in a home setting. The standardization of the requirements for prefilled syringes has been addressed by ISO/TC 76 in two ways: — the specifications of the components of the prefilled syringe prior to filling are included in the previous parts of the ISO 11040 series; — the requirements for the final prefilled syringe, presented to the user as a finished product, are addressed in this document. Finished prefilled syringes can require marketing authorization as a medicinal product, in some regions as a combination product or as a medical device, depending on their contents and the intended use. The syringe plays a dual role in the finished product — as a container closure system and as a delivery device. Safety, functional performance and usability need to be considered, also
Scope: This document is applicable to aseptically processed or terminally sterilized finished prefilled syringes (intended for single use only) based on syringe barrel components addressed in ISO 11040-4 or ISO 11040-6, together with a plunger stopper (sealing the back end) based on components addressed in ISO 11040-5 and a front end closure for parenteral preparations with focus on quality, functional performance and safety requirements, as well as relevant test methods. Finished prefilled syringes which have undergone an additional preparation step by the user before injection (e.g. diluent-containing syringes that have been emptied for reconstitution and in which the reconstituted injectable product has been aspirated after reconstitution) are excluded from the scope of this document. NOTE 1 This document can also be used as a guidance for other types, designs and/or sizes of finished prefilled syringes, for example dual chamber prefilled syringes. NOTE 2 For finished prefilled syringes that are used in needle-based injection systems, see also ISO 11608 (all parts) [1]. NOTE 3 Attention is drawn to applicable national or regional regulations and pharmacopoeias, such as Ph.Eur. [2], USP [3] or JP [4]. NOTE 4 Finished prefilled syringes for parenteral preparations which are medical devices or which, according to the principal mode of action of the product (i.e. the means by which the product achieves its principal intended action), are borderline between medical devices and medicinal products fall within the scope of this document, even if they are not always regulated as medicinal products.